TGFB1 and neoplasm: The treatment of TGF-β-activated tumor cells by SM effectively shifted the expression of EMT-associated markers to epithelial-type one: it was shown that SM increased the expression of E-cadherin by 3.3-fold and decreased the expression of fibronectin by 1.9-fold compared to TGF-β-stimulated cells (Figure 6A).